Subscribe to RSS

DOI: 10.1055/a-2734-7103
Corynebacterium Infection Following Implant-based Breast Reconstruction: Lessons from the Five Consecutive Patients
Authors
Abstract
Background
Infection is a challenging complication in prosthetic breast reconstruction. Recently, we encountered cases of Corynebacterium striatum infection following prosthetic breast reconstruction in breast cancer patients. We would like to share our experience of preventing reconstruction failure from this uncommon infection.
Methods
This is a retrospective study on consecutive cases of Corynebacterium infection that occurred within 2 months in five patients who underwent implant-based breast reconstruction. One patient had a history of preoperative radiation therapy, one required reoperation due to postoperative bleeding, and two experienced hemovac obstruction events. Patients were immediately hospitalized and treated with hemovac insertion, IV antibiotics, and, if necessary, reoperation for salvage.
Results
Corynebacterium striatum was identified in the hemovac cultures or intraoperative specimens of all patients. Based on the antibiotic susceptibility of the identified strain, infection with a single bacterial strain was suspected. All patients underwent hemovac re-insertion, and one patient was successfully salvaged with IV antibiotic treatment alone. However, the remaining four patients required implant change during the salvage process. The bacteria became negative within a period ranging from 1 to 7 weeks after identification, and salvage was successfully achieved without reconstruction failure in all patients by postoperative days 20 to 58.
Conclusion
Corynebacterium is an uncommon pathogen in implant-based breast reconstruction, and reports of its treatment are very rare. This study presents our experience with successful treatment and outlines the clinical symptoms and treatment methods. We hope that this report can serve as a reference for reconstructive surgeons who may encounter similar situations.
Contributors' Statement
J.K. drafted the article and critically revised it.
M.P. contributed significantly in data acquisition, data analysis and interpretation.
S.Y.S. contributed in conception/design, critical revising and final approval.
Ethical Approval
This study is approved by Institutional Review Board of Severance Hospital (IRB No. 4–2025–0061).
Informed Consent
The patients provided written informed consent for the publication and the use of their images.
Publication History
Received: 10 March 2025
Accepted: 28 October 2025
Accepted Manuscript online:
30 October 2025
Article published online:
30 January 2026
© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Reish RG, Damjanovic B, Austen Jr WG. et al. Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success. Plast Reconstr Surg 2013; 131 (06) 1223-1230
- 2 Song JH, Kim YS, Jung BK. et al. Salvage of infected breast implants. Arch Plast Surg 2017; 44 (06) 516-522
- 3 Meshkin DH, Firriolo JM, Karp NS, Salibian AA. Management of complications following implant-based breast reconstruction: a narrative review. Ann Transl Med 2023; 11 (12) 416
- 4 Mesa F, Cataño S, Tuberquia O. Study of infections in breast augmentation surgery with implants in 9,691 patients over 5 years. Plast Reconstr Surg Glob Open 2021; 9 (08) e3752
- 5 Oliva A, Belvisi V, Iannetta M. et al. Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device. J Clin Microbiol 2010; 48 (12) 4669-4671
- 6 de Arriba JJ, Blanch JJ, Mateos F, Martínez-Alfaro E, Solera J. Corynebacterium striatum first reported case of prosthetic valve endocarditis. J Infect 2002; 44 (03) 193
- 7 Seutz Y, Bäcker H, Akgün D. et al. Corynebacterium periprosthetic joint infection: a systematic review of 52 cases at 2.5 years follow-up. Arch Orthop Trauma Surg 2023; 143 (09) 5527-5538
- 8 Kumar MB, Pahil S, Yadav S. et al. Diptheroids can cause nosocomial UTI and be multidrug resistant: a case report of Corynebacterium striatum, first from India. Indian J Med Microbiol 2024; 47: 100513
- 9 Silva-Santana G, Silva CMF, Olivella JGB. et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976-2020. Arch Microbiol 2021; 203 (05) 1863-1880
- 10 Souza Cd, Faria YV, Sant'Anna LdeO. et al. Biofilm production by multiresistant Corynebacterium striatum associated with nosocomial outbreak. Mem Inst Oswaldo Cruz 2015; 110 (02) 242-248
- 11 Lee MY, Lee JY, Lew DH, Song SY. The use of an ultrasonic dissection device for the P1 method in prosthetic breast reconstruction. Arch Aesthetic Plast Surg 2024; 30 (04) 126-131
- 12 Lee PP, Ferguson Jr DA, Sarubbi FA. Corynebacterium striatum: an underappreciated community and nosocomial pathogen. J Infect 2005; 50 (04) 338-343
- 13 Boltin D, Katzir M, Bugoslavsky V. et al. Corynebacterium striatum—a classic pathogen eluding diagnosis. Eur J Intern Med 2009; 20 (03) e49-e52
- 14 Orosz L, Sóki J, Kókai D, Burián K. Corynebacterium striatum—got worse by a pandemic?. Pathogens 2022; 11 (06) 685
- 15 Kang Y, Chen S, Zheng B. et al. Epidemiological investigation of hospital transmission of Corynebacterium striatum infection by core genome multilocus sequence typing approach. Microbiol Spectr 2023; 11 (01) e0149022
- 16 McMullen AR, Anderson N, Wallace MA, Shupe A, Burnham CA. When good bugs go bad: epidemiology and antimicrobial resistance profiles of Corynebacterium striatum, an emerging multidrug-resistant, opportunistic pathogen. Antimicrob Agents Chemother 2017; 61 (11) e01111-e01117
- 17 Souza C, Simpson-Louredo L, Mota HF. et al. Virulence potential of Corynebacterium striatum towards Caenorhabditis elegans. Antonie van Leeuwenhoek 2019; 112 (09) 1331-1340
- 18 Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN. In vitro antibiotic susceptibility pattern of non-diphtheriae Corynebacterium isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother 2018; 62 (04) e01776-e17
- 19 Asgin N, Otlu B. Antimicrobial resistance and molecular epidemiology of Corynebacterium striatum isolated in a tertiary hospital in Turkey. Pathogens 2020; 9 (02) 136
- 20 Milosavljevic MN, Milosavljevic JZ, Kocovic AG. et al. Antimicrobial treatment of Corynebacterium striatum invasive infections: a systematic review. Rev Inst Med Trop São Paulo 2021; 63: e49
- 21 Papa G, Frasca A, Renzi N. et al. Protocol for prevention and monitoring of surgical site infections in implant-based breast reconstruction: preliminary results. Medicina (Kaunas) 2021; 57 (02) 151